Status:

COMPLETED

Labour Augmentation by Means of Oxytocin - Obstetric Outcome and Women's Experiences

Lead Sponsor:

Göteborg University

Collaborating Sponsors:

Sahlgrenska University Hospital

Ryhov County Hospital

Conditions:

Slow Labour Progress

Eligibility:

FEMALE

18-48 years

Phase:

NA

Brief Summary

Slow labour progress is common in nulliparous women and is associated with childbirth complications and negative birth experiences. Oxytocin augmentation is widely used to treat slow labour despite as...

Detailed Description

In contemporary handling of labouring women in the western world, it has become extremely common to intervene through "active" or disciplined" management (Enkin et al., Widela et al., Gerdhardstein et...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Nulliparity Normal pregnancy 37+0 - 41+6 weeks Single foetus Cephalic presentation Spontaneous onset of active labour Informed consent
  • Exclusion Criteria:
  • Prelabour rupture of membranes Serious maternal disease Fetal intrauterine death

Exclusion

    Key Trial Info

    Start Date :

    October 1 1998

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2003

    Estimated Enrollment :

    2072 Patients enrolled

    Trial Details

    Trial ID

    NCT01263158

    Start Date

    October 1 1998

    End Date

    December 1 2003

    Last Update

    August 11 2015

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Institute of Health and Care Sciences, University of Gothenburg

    Gothenburg, Sweden, 40530